Vagal paragangliomas: a clinical, pathological, and DNA assessment

Abstract

Ten vagal paragangliomas were studied by image analysis and the results correlated with clinicopathologic features to determine if the DNA ploidy pattern could be used to separate benign from malignant paragangliomas. The tumours occurred in 8 women and 2 men ranging in age from 23 to 75 years (average 54 years). Follow‐up was available in all 10 patients and ranged from 3 months to 27 years (average 7.8 years). Of the 10 tumours examined for DNA, 5 were diploid, 4 diploid‐tetraploid, and 1 aneuploid. Two patients experienced local recurrences. One of these had a diploid tumour that recurred 22 years after excision and the other had an aneuploid tumour which recurred 4 years 4 months later and was associated with cervical lymph node metastasis. Two patients had malignant tumours with histologically confirmed metastases to noncontiguous cervical lymph nodes. One of the malignant tumours was diploid and the other aneuploid. This study concludes that DNA abnormalities are common in vagal paragangliomas and that tumour ploidy can not be used to assess malignant potential.

Paragangliomas of the Head and Neck: An Overview from Diagnosis to Genetics

“…For over 3 decades, Dr. Barnes has brought attention to PGLs. He recognized the need to critically analyze these tumors both histologically and molecularly with an aim to delineate biomarkers of aggressive behavior [42,43]. The current biologic understanding of PGLs is that they are tumors of indeterminate behavior and should not be classified as benign.…”